1Balestrazzi P, Baeteman MA, Mattei MG, et al. Franceschetti syndrome in a child with a de novo balanced translocation (5;13)( qll;pll) and significant decrease of hexosaminidase B. Hum Genet, 1983,64: 305-308.
2Jabs EW, Li X, Coss CA, et al. Mapping the Treacher Collins syndrome locus to 5q31.3-q33.3. Genomics, 1991,11:193-192.
3Dixon M J, Dixon J, Houseal T, et al. Narrowing the position of the Treacher Collins syndrome locus to a small interval between three new microsatellite markers at 5q32-33.1. Am J Hum Genet, 1993,52:907-914.
4Treacher Collins Syndrome Collaborative Group. Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nature Genet, 1996,12:130-136.
5Gladwin A J, Dixon J, Loftus SK, et al. Treacher Collins syndrome may result from insertions, deletions, or splicing mutations, which introduce a termination codon into the gene. Hum Molcc Genet, 1996,5: 1533-1538.
6Edwards SJ, Gladwin A J, Dixon MJ. The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am J Hum Genet, 1997,60: 515-524.
7Splendore A, Silva EO, Alonsl LG, et al. High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum Mutat, 2000,16:315-322.
8Splendore A, Passos Bueno MR, Jabs EW, et al. TCOF1 mutations excluded from a role in other first and second branchial arch-related disorders. Am J Med Genet, 2002,111: 324-327.
9Marszalek B, Wojcicki P, Kobus K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl. Genet,2002,43: 223-233.
